Biophysical Assessments of Acupuncture Points in Inflammatory Bowel Disease

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBrigham and Women's Hospital

About this trial

Acupuncture points or acupoints are fundamental to the practice of acupuncture, yet their scientific basis remains unclear. According to traditional explanations of acupuncture, acupoints can become tender or more sensitive to pressure when there is an underlying disease of the body. Findings from recent basic animal studies support this traditional theory. For example, compared to healthy control animals, models of colitis have shown increased skin temperature, blood flow, and pain sensitivity at specific body regions that correspond to the location of acupoints that are commonly used in acupuncture treatment for colitis. However, little is known about whether these findings apply to humans.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

adults (age 18 years or older)

clinical diagnosis of ulcerative colitis or Crohn's disease

Disqualifiers

any history of serious musculoskeletal or soft tissue injury of the lower and/or upper extremities

presence of scarring or tattoo on the lower and/or upper extremities

presence of serious cardiac diseases, severe dermatological conditions, peripheral neuropathy, infectious disease, psychological illnesses, or other serious co-morbidities (e.g., cancer)

prior history of colostomy or ileostomy

Trial population

Adults with inflammatory bowel disease (IBD) and healthy control participants will be enrolled into the study from the Greater Boston area.

Trial design

Design model

Other

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

100 Participants
are grouped into 2 trial groups
Group A: IBD
Group B: Control

Trial outcomes

Primary outcomes

1

Skin blood perfusion

Comparisons of cutaneous blood perfusion at predefined regions or points of interest between IBD patients and healthy control participants, as measured by laser speckle contrast imaging (LSCI). LSCI is a non-invasive imaging technique for assessing superficial tissue blood perfusion.

Time frame
1 day
2

Skin temperature

Comparisons of skin temperature at predefined regions or points of interest between IBD patients and healthy control participants, as measured by infrared thermography.

Time frame
1 day
3

Pressure pain threshold

Comparisons of pressure pain threshold (PPT) at predefined points of interest between IBD patients and healthy control participants, as measured by pressure algometry.

Time frame
1 day

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Brigham and Women's Hospital

Lead sponsor

National Center for Complementary and Integrative Health (NCCIH)

Collaborator

This trial is not recruiting at the moment. You can still explore other options: